No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Launch of Apex Laser Series, the World’s First and Only High-Powered Multi-Wavelength Laser for Photobiomodulation

Editor: What To Know

  • Launch of Apex Laser Series is the newest addition to the premium Aspen Laser family, positioning it ahead of the market as a flagship solution in photobiomodulation (laser therapy) reports Aspen Laser Systems.
  • “This product has been in research and development for the past two years, and because of the broad range of power, wavelengths and operating mode choices, it is a wonderful support for our Patient Response Driven Clinical Protocols.
  • In addition to the Apex Tri-Wave 45 watt model, the Apex Laser Series includes a Dual-Wave Laser model option featuring 60 watts of total output with 30 watts each of 810nm and 1064nm (or 980nm) wavelengths.

Launch of Apex Laser Series is the newest addition to the premium Aspen Laser family, positioning it ahead of the market as a flagship solution in photobiomodulation (laser therapy) reports Aspen Laser Systems.

The Apex Tri-Wave Laser model is the world’s first and only therapy laser that features three therapeutic wavelengths: 810nm, 980nm and 1064nm, each with the capability of operating at a max power of 15 watts and a combined total output of 45 watts.

With this new product launch, Aspen Laser introduces the 1064nm wavelength to the US market. The 1064nm wavelength is a longer wavelength that can penetrate deeper into tissue. Clinical studies indicate that it has the least dispersion within biological tissues due to its decreased melanin absorption. The result is deep activation of metabolic processes vital for all cellular activities.

The Apex Laser Series allows healthcare practitioners a new and effective clinical tool to deliver optimal outcomes. This new model combines exclusive high average power PowerDose diodes and advanced Wavelength MultiPlexer Technology to provide the broadest range and selections of therapeutic wavelengths. In addition to the Apex Tri-Wave 45 watt model, the Apex Laser Series includes a Dual-Wave Laser model option featuring 60 watts of total output with 30 watts each of 810nm and 1064nm (or 980nm) wavelengths. The Apex Dual-Wave Laser model is also the only one of its kind in the world.

“The Apex Laser Series is surpassing the results that we originally planned for,” said Charles Vorwaller, CEO of Aspen Laser Systems, LLC. “This product has been in research and development for the past two years, and because of the broad range of power, wavelengths and operating mode choices, it is a wonderful support for our Patient Response Driven Clinical Protocols. This means a healthcare professional will have significantly better outcomes and physiological effects that include increased circulation, reduced inflammation, pain reduction and enhanced tissue healing. The Apex Laser Series is a great addition for any healthcare professional, whether experienced or just starting out with photobiomodulation.”

Photobiomodulation is a non-invasive and painless treatment used to treat pain and inflammation from conditions such as arthritis, tendonitis, and acute joint or muscle injuries, and the treatment can be applied to both humans and animals. Instead of just treating symptoms that may provide temporary benefits, photobiomodulation is a superior treatment option because it provides energy to cells that trigger a chemical response resulting in the body to heal itself.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy